Evaluating Day +90 Donor Chimerism as a Prognostic Marker of Clinical Outcomes Among Allogeneic Hematopoietic Cell Transplant Recipients Who Received Myeloablative Conditioning

Sara Jubas, Kieran Collins, Kendall Obara, Hsuan-Hui (Grace) Liu, Ryan M. Kemper, Alexandra L.W. Kelley, Arushi Goel, Tyler C. Dunlap, Jing Zhu, Riley M. Randolph, Jonathan R. Ptachcinski, Morgan E. Bizzell, Paul M. Armistead, Ryan Shaw, Anson E. Snow, Daniel J. Crona

Open source

DOI: 10.1016/j.jtct.2026.06.024
Published: 2026-06
Container: Transplantation and Cellular Therapy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.06.024,
  title = {Evaluating Day +90 Donor Chimerism as a Prognostic Marker of Clinical Outcomes Among Allogeneic Hematopoietic Cell Transplant Recipients Who Received Myeloablative Conditioning},
  author = {Sara Jubas and Kieran Collins and Kendall Obara and Hsuan-Hui (Grace) Liu and Ryan M. Kemper and Alexandra L.W. Kelley and Arushi Goel and Tyler C. Dunlap and Jing Zhu and Riley M. Randolph and Jonathan R. Ptachcinski and Morgan E. Bizzell and Paul M. Armistead and Ryan Shaw and Anson E. Snow and Daniel J. Crona},
  year = {2026},
  journal = {Transplantation and Cellular Therapy},
  doi = {10.1016/j.jtct.2026.06.024},
  url = {https://doi.org/10.1016/j.jtct.2026.06.024}
}

RIS

TY  - JOUR
TI  - Evaluating Day +90 Donor Chimerism as a Prognostic Marker of Clinical Outcomes Among Allogeneic Hematopoietic Cell Transplant Recipients Who Received Myeloablative Conditioning
AU  - Sara Jubas
AU  - Kieran Collins
AU  - Kendall Obara
AU  - Hsuan-Hui (Grace) Liu
AU  - Ryan M. Kemper
AU  - Alexandra L.W. Kelley
AU  - Arushi Goel
AU  - Tyler C. Dunlap
AU  - Jing Zhu
AU  - Riley M. Randolph
AU  - Jonathan R. Ptachcinski
AU  - Morgan E. Bizzell
AU  - Paul M. Armistead
AU  - Ryan Shaw
AU  - Anson E. Snow
AU  - Daniel J. Crona
PY  - 2026
JO  - Transplantation and Cellular Therapy
DO  - 10.1016/j.jtct.2026.06.024
UR  - https://doi.org/10.1016/j.jtct.2026.06.024
ER  -

APA

Jubas, S., Collins, K., Obara, K., Liu, H. (., Kemper, R. M., Kelley, A. L., Goel, A., Dunlap, T. C., Zhu, J., Randolph, R. M., Ptachcinski, J. R., Bizzell, M. E., Armistead, P. M., Shaw, R., Snow, A. E., & Crona, D. J. (2026). Evaluating Day +90 Donor Chimerism as a Prognostic Marker of Clinical Outcomes Among Allogeneic Hematopoietic Cell Transplant Recipients Who Received Myeloablative Conditioning. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.06.024

Source records

crossref · retrieved 2026-09-25T02:20:44.033Z